Expression of CD39 is upregulated on several solid tumors (including colorectal, pancreatic, head and neck cancer), implicating the CD39/CD73 adenosine pathway in the pathogenesis of a number of malignancies (32). This evidence concerns the gene NT5E and head and neck cancer.